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Abstract
Background: Phosphorylation is the most frequent post-translational modification made to proteins and may regulate
protein activity as either a molecular digital switch or a rheostat. Despite the cornucopia of high-throughput (HTP)
phosphoproteomic data in the last decade, it remains unclear how many proteins are phosphorylated and how many
phosphorylation sites (p-sites) can exist in total within a eukaryotic proteome. We present the first reliable estimates of the
total number of phosphoproteins and p-sites for four eukaryotes (human, mouse, Arabidopsis, and yeast). Results: In all, 187
HTP phosphoproteomic datasets were filtered, compiled, and studied along with two low-throughput (LTP) compendia.
Estimates of the number of phosphoproteins and p-sites were inferred by two methods: Capture-Recapture, and fitting the
saturation curve of cumulative redundant vs. cumulative non-redundant phosphoproteins/p-sites. Estimates were also
adjusted for different levels of noise within the individual datasets and other confounding factors. We estimate that in
total, 13 000, 11 000, and 3000 phosphoproteins and 230000, 156 000, and 40000 p-sites exist in human, mouse, and yeast,
respectively, whereas estimates for Arabidopsis were not as reliable. Conclusions: Most of the phosphoproteins have been
discovered for human, mouse, and yeast, while the dataset for Arabidopsis is still far from complete. The datasets for p-sites
are not as close to saturation as those for phosphoproteins. Integration of the LTP data suggests that current HTP
phosphoproteomics appears to be capable of capturing 70% to 95% of total phosphoproteins, but only 40% to 60% of total
p-sites.
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Background
Phosphorylation is the most frequent post-translational modi-
fication made to proteins [1] and may regulate protein activity
as either a molecular digital switch or a rheostat. Enzyme activ-
ity, complex formation, subcellular localization, or degradation
are some of the functions that may be regulated via allosteric
or orthosteric effects [2]. Phosphorylation/dephosphorylation is
also a key component of signal transduction. More than one
switch of this kind may be present in a protein and phospho-
rylation events may be independent of each other, or there may
be interdependencies between them or even with other types of
switches [3]. In addition, phosphorylation affects the evolution
of a genome [4].
It is of paramount importance to know which proteins are
phosphorylated and onwhich of their amino acids. In spite of all
this, it remains unclear how many proteins are phosphorylated
and howmany phosphorylation sites (p-sites) can exist within a
proteome. This questionwill be answeredwhen all of themhave
been identified and novel ones are no longer discovered. Until
that point has been reached, however, it is necessary to have
a reasonable estimate of their total numbers. Such an estimate
will permit us to determine the limits of our current knowledge
and will allow us to appreciate howmuch still remains to be dis-
covered. It will also provide a critical evaluation of the efficacy of
current approaches and indicate what novel strategies and tech-
nologies will need to be developed to achieve the ultimate goal
of obtaining a comprehensive inventory of all phosphoproteins,
their p-sites, and the physiological and developmental contexts
in which they are modified.
At present, values for these numbers remain in the realm
of speculation. It has been suggested that the biological ac-
tivity of between one-third and two-thirds of an organism’s
proteome could be regulated by protein phosphorylation [5–8].
In the specific case of the human proteome, it has been pro-
posed that 57 000, 500 000, 700 000, or even 1000 000 p-sites
may exist [9–12]. Sharma et al. performed a deep phosphopro-
teome analysis on HeLa cells and estimated that at least 75%
of the proteome expressed in those cells can be phosphory-
lated, and this number may well rise to 90% if phosphopro-
teomic experiments are performed at higher coverage [13]. In
an effort to provide a reasonable and statistically defensible es-
timate based on current knowledge, we have mined over 1000
articles from the literature and gathered and filtered 187 pub-
licly available HTP phosphoproteomic datasets from four well-
studied species. By implementing two independent statistical
methods, the Capture-Recapture method and Curve-Fitting on
the saturation curve of redundant phosphoproteins/p-sites vs
non-redundant phosphoproteins/p-sites, we have obtained, for
the first time, a reliable estimate of their total number for hu-
mans and three other model eukaryotes.
Data description
Over 1000 relevant articles were retrieved from PubMed with
the keywords “phosphoproteomic OR phosphoproteomics” and
were manually inspected for available raw data in human,
mouse, Arabidopsis (Arabidopsis thaliana), and yeast (S. cerevisiae).
Only articles that provided the sequences of phosphopeptides
and the exact p-site location with algorithm-specific confidence
scores were retained. These phosphopeptides were further fil-
tered with a cut-off criterion of 99% correct phosphopeptide
sequence identification and 99% correct p-site localization
to ensure that only data of very high quality were used in
the subsequent analyses. Finally, phosphopeptides that exactly
matched two or more genes/proteins were removed. Thus, 97,
42, 28, and 20 HTP datasets were retained for human, mouse,
Arabidopsis, and budding yeast, respectively (see supplementary
files S1-S5). The human and mouse proteomes were retrieved
from ENSEMBL VEGA based on the GRCh38 and GRCm38 ref-
erence assemblies, respectively (December 2015) [14]. For every
protein-encoding gene that was annotated by VEGA, only the
longest peptide was retained. The Arabidopsis proteome was re-
trieved from TAIR 10 [15], whereas the budding yeast proteome
was derived from the Saccharomyces Genome Database [16].
Human and mouse p-sites that were identified by LTP tech-
nologies are considered to be of higher quality/confidence and
were retrieved from the Phosphosite plus database [17]. The
downloaded phospho-motifs were mapped to the Ensembl pep-
tide sequences. Only p-sites whose coordinatesmatched exactly
between the Swissprot (provided by Phosphosite-plus) and En-
sembl proteins were retained. Yeast LTP p-sites were retrieved
from the PhosphoGrid2 database [8, 18]. No LTP compendium
was available for Arabidopsis.
Analyses
Estimation of the total number of yeast phosphoproteins and p-sites
S. cerevisiae (budding yeast) is the best-studied unicellular eu-
karyote and harbours only ∼6000 proteins [19,20]. Twenty HTP
phosphoproteomic datasets from 18 articles have been collected
from this organism, under a reasonably wide range of condi-
tions, and more than 70% of its entire proteome is detectable
by MS/MS technology in a single experiment [21,22]. In addi-
tion, a very comprehensive compendium of LTP, but high qual-
ity, p-sites has been compiled by the PhosphoGrid2 database [8].
Therefore, yeast is the ideal system with which to estimate the
total number of phosphoproteins and p-sites. For these reasons,
wewill describe the complete process of the analyses performed
on the yeast proteome to illustrate our approach. We will then
summarize the outcomes of similar analyses performed with
the proteomes of the other three species examined.
To date, 2587 phosphoproteins and 13244 p-sites (2633 and
14341 including the PhosphoGrid LTP data; see supplementary
file S1) have been discovered, probably with some of them be-
ing false-positives. The saturation level of the yeast phospho-
proteins (based on the HTP data) is depicted in Fig. 1A, whereas
the estimates of their total number, based on different methods
and data treatments, is depicted in Fig. 1B. It is evident, espe-
cially from Fig. 1A, that the detection of phosphoproteins with
HTP methods has approached saturation. Assuming 1 % noise
in each experiment, the Curve-Fitting method estimates ∼2400
true-positive phosphoproteins, whereas the Capture-Recapture
method estimates ∼2800. In addition, curve-fitting estimates
based on highly confident phosphoproteins that have been de-
tected in three or more experiments (this criterion is based on
a previous analysis [5], designated as 3X) suggests a total of
∼2300 phosphoproteins. Therefore a gross estimate of 2300 to
2800 phosphoproteins, ∼40% to 50% of the proteome, seems a
reasonable one, based solely on the current HTP technologies.
These conclusions appear robust, even if the order of the largest
experiment is perturbed (as first –best start in graph; or last –
best end in graphs; in the series) and even if only one-half of
the experiments are used in Curve-Fitting (see Fig. 1B). Interest-
ingly, Beltrao et al. also suggested that HTP phosphoproteomic
studies have revealed about 80% to 90% of all S. cerevisiae phos-
phoproteins [23].
Estimating phosphoproteins and phosphorylation sites 3
Figure 1: Estimation of the total number of phosphoproteins (1A, 1B) and p-sites (1C, 1D) for yeast, with the curve-fitting (assuming 1 % noise) and Capture-Recapture
methods, also correcting for three levels of noise (1 %, 5%, 10%). In Fig. 1A and C, the x-axis is the cumulative number of redundant phosphoproteins/p-sites, whereas
the y-axis is the cumulative number of non-redundant phosphoproteins/p-sites. The red curve is fitted for 1 % noise. In Fig. 1B and D: Current is the total number
of phosphoproteins/p-sites detected so far (by applying our filtering criteria). Current 3X is the total number of phosphoproteins/p-sites detected so far in at least
three experiments. Rcapture is the estimation of maximum number of phosphoproteins/p-sites based on the Rcapture method (using the 15 largest datasets). Rcap-
ture HTP vs LTP is the estimation of maximum number of phosphoproteins/p-sites based on the Rcapture method, but this time using only two datasets, where one
of them is the compendium of all HTP experiments and the second is the compendium of all LTP experiments from PhosphoGrid2. CF is the estimation of maximum
number of phosphoproteins/p-sites based on the curve-fitting method of the saturation curve from all experiments. CF 3X is the estimation of maximum number of
phosphoproteins/p-sites identified in at least three experiments, based on the curve-fitting method (in this case, a reasonable estimate was not possible). CF best start
is the estimation of maximum number of phosphoproteins/p-sites based on the curve-fitting method of the saturation curve from all experiments, but this time, the
largest experiment is used as first in the series. CF best end is the estimation of maximum number of phosphoproteins/p-sites based on the curve-fitting method of
the saturation curve from all experiments, but this time, the largest experiment is used as last in the series. CF half exp is the estimation of maximum number of
phosphoproteins/p-sites based on the curve-fitting method of the saturation curve from the first half experiments.
Concerning the saturation level of p-sites, it is evident, es-
pecially from Fig. 1C, that their detection is approaching satura-
tion, although this trend is less marked than it is for the total
number of phosphoproteins. Assuming 1 % noise in each exper-
iment, the Curve-Fitting method estimates ∼15 000 true positive
p-sites, whereas the Capture-Recapture method raises this esti-
mate to ∼21 000. Curve-Fitting based on highly confident p-sites
that have been detected in three or more experiments failed to
provide a reasonable estimate.
The above estimates are based solely on 20 HTP experiments.
Nevertheless, several experimental and computational studies
have reported that HTP phosphoproteomic experimentsmay fail
to capture many known p-sites, depending on various param-
eters and protocols [5,18,24–28]. To control for this factor, the
LTP (high confidence) data fromPhosphoGrid2were employed as
well andweremerged into one non-redundant LTP dataset. Sim-
ilarly, all HTP experimentsweremerged into one non-redundant
HTP dataset. Next, the Capture-Recapture method was imple-
mented by using as input two datasets, themerged HTP one and
the PhosphoGrid2 LTP one. This time, the estimate significantly
increased from 21000 to 40 000 p-sites. On the contrary,
the equivalent analysis estimated 2951 total phosphoproteins,
which is very close to the one generated by the Capture-
Recapture method (2772) that used the 15 largest HTP datasets
individually. We believe that the analysis incorporating the LTP
data provides a more realistic total estimate than an analysis
based solely on HTP data. Consequently, the current HTP tech-
nologies have the potential to capture the vast majority (94%) of
the yeast phosphoproteome but only ∼53% of the total p-sites.
Similar analyses to those performed on the S. cerevisiae pro-
teome were also executed with three other species. The results
are presented in Figs 2 (Homo sapiens), 3 (Mus musculus), and 4
(Arabidopisis thaliana), and Table 1 compares the outcomes of the
analyses of all four proteomes. In the table, the most reliable
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Table 1: Estimates on the total number of phosphoproteins and p-sites for the various species, based on different analyses.
Human Mouse Arabidopsis Yeast
Proteins current 10 456 6512 4930 2587
current 3X 6683 3827 1815 1630
Rcapture HTP vs LTP 12844 11 190 NA 2951
Rcapture 1 % noise 10 239 8346 6531 2772
CF 1 % noise 9160 7213 4292 2373
CF 3X 7582 6789 NA 2297
CF best start 1 % noise 8803 7167 4558 2328
CF best end 1 % noise 8775 7099 4292 2304
CF half exp 1 % noise 7885 6329 2373 2257
P-sites current 86 181 36 438 14 796 13244
current 3X 27110 10 384 3078 4156
Rcapture HTP vs LTP 229 616 155 668 NA 40350
Rcapture 1 % noise 124 985 71 456 27 815 21343
CF 1 % noise 94 670 54 031 23 531 14533
CF 3X 91500 NA 34457 NA
CF best start 1 % noise 82 092 45 797 15 122 12962
CF best end 1 % noise 86 723 49 122 23 531 14496
CF half exp 1 % noise 89 639 36 615 6016 11980
Second column denotes the analysis and datasets: current: experimentally identified; current 3X: experimentally identified in three or more experiments; Rcap-
ture HTP vs LTP: The Capture-Recapture analysis that used the HTP compendium and the LTP compendium (shown in bold as the most reliable estimate); Rcapture 1
% noise: The Capture-Recapture analysis assuming 1 % noise in each dataset; CF 1 % noise: The Curve-Fitting analysis assuming 1 % noise; CF 3X: The Curve-Fitting
analysis based on the datasets that have been identified in three or more experiments. CF best start 1 % noise: The Curve-Fitting analysis assuming 1 % noise and
changing the order of the largest experiment as first; CF best end 1 % noise: The Curve-Fitting analysis assuming 1 % noise and changing the order of the largest
experiment as last; CF half exp 1 % noise: The Curve-Fitting analysis assuming 1 % noise and using only the first half of experiments.
estimates, obtained by incorporating both the HTP and LTP non-
redundant datasets, are highlighted in bold.
Estimation of the total number of phosphoproteins and p-sites in the
two mammalian proteomes
As expected, the organism with the most data is Homo sapi-
ens, where 97 HTP experimental datasets have so far generated
86 181 p-sites in 10 456 phosphoproteins (see supplementary file
S2), using the samefiltering criteria as yeast.Mouse is amammal
that is used extensively as a model for understanding human
biology and is a rather close evolutionary relative of our own
species with a time divergence of about 90 million years. Bud-
ding yeast, by comparison, is a unicellular fungus that diverged
from its most-recent common ancestor with humans ∼1.3 bil-
lion years ago [29]. In addition, human and mouse have a very
similar number of protein-coding genes, ∼20 000 [30,31]. There-
fore, estimates on the mouse phosphoproteome and p-sites are
expected to be of the same magnitude as those for human,
thus serving as a quality control for our estimates for humans,
above. Nevertheless, the number of publicly available datasets
formouse is not as high, with 42 HTP experimental datasets that
generated (with our stringent filtering criteria) 36 438 detected
p-sites in 6512 phosphoproteins so far (see supplementary file
S3). Of note, in our analyses, the VEGA annotated mouse pro-
teome was used; this consists of ∼16000 protein-coding genes,
although the total number is estimated at∼20 000. Therefore, all
mouse estimates obtained in this analysis have been adjusted
upwards by 25% to make reasonable estimates for the complete
mouse proteome and not for the VEGA highly annotated subset.
It is evident, especially from Fig. 2A, that the detection of
phosphoproteins (based on HTP data) in the human proteome
has approached saturation, while that for mouse phosphopro-
teins (Fig. 3A) has yet to plateau. Based on the HTP data alone,
the Capture-Recapture method estimates 10 200 true-positive
phosphoproteins for humans compared to ∼8300 for mouse
(both with an assumed error rate of 1 %). A jackknife analysis on
the Capture-Recapturemethod suggested 8500± 960 and 8600±
530 phosphoproteins as the lower bound for human andmouse,
respectively. It should be noted that the jackknife analyses do
not use the largest 15 datasets, but randomly selected ones.
The Curve-Fitting method (with 1 % error rate, whenever ap-
plicable) on the HTP data and their various perturbations (or-
der of largest experiment, using half the datasets, using phos-
phoproteins detected in three or more experiments) estimates
7600 to 9200 and 6300 to 7200 phosphoproteins for human and
mouse, respectively. From these combined analyses of Capture-
Recapture and Curve-Fitting on HTP data alone, gross estimates
of 7600 to 10 200 phosphoproteins in humans and 6300 to 8300 in
mouse appears reasonable. It is reassuring that the estimates for
the mouse phosphoproteome are not so different from those for
the human despite the fact that there are ∼50% fewer datasets
for mouse.
Concerning the saturation level of p-sites, Figs. 2C and 3C
suggest that their detection (based on HTP data alone) in hu-
man andmouse is approaching saturation, but less rapidly than
are the phosphoprotein data (a similar disparity was observed
with yeast, above). The Capture-Recapture method on the HTP
data estimates 125 000 p-sites for human and 71000 formouse. A
jackknife analysis on the Capture-Recapture method suggested
69000 ± 18000 and 46000 ± 8000 p-sites as the lower bound for
human and mouse, respectively.
The Curve-Fitting method (assuming 1 % error rate) on the
HTP data and their various perturbations (order of largest exper-
iment, using half the datasets, using p-sites detected in three or
more experiments) estimate 82 000 to 95 000 and 37000 to 54 000
p-sites for human and mouse, respectively. Of note, no reason-
able estimate was obtained for mouse when using p-sites de-
tected in three or more experiments.
The above estimates are based solely on 97 (human) and
42 (mouse) HTP experiments. To control for the fact that HTP
technologies may not be able to detect the whole phospho-
proteome, a compendium of LTP phosphoproteins/p-sites from
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Figure 2: Estimation of the number of phosphoproteins (2A, 2B) and p-sites (2C, 2D) for human, with the Curve-Fitting (assuming 1 % noise) and Capture-Recapture
methods, also correcting for various levels of noise (1 %, 5%, 10%). See legend of Fig. 1 for explanations.
Phosphosite plus was used. In addition, all HTP experiments
were merged into one non-redundant HTP dataset for each
species separately. This time, the Capture-Recapture method
was implemented in each species separately by using as in-
put two datasets (instead of 15 individual ones as before), the
merged HTP one and the Phosphosite LTP one. Notably, the
maximum estimate of total p-sites significantly increased from
125000 to 230 000 for human and from 71000 to 156 000 for
mouse. In contrast, the equivalent increase of maximum esti-
mate for phosphoproteins was from 10200 to 12 800 for human
and from 8300 to 11 200 for mouse. A reasonable interpretation
is that the Capture-Recapture estimates that employ the LTP
data are more realistic and that the current HTP technologies
alone have the potential to capture the majority of the human
(80%) and mouse (74%) phosphoproteome, but only 54% and
46% of their total p-sites. The estimates of the number of mouse
phosphoproteins and p-sites are about 13% and 32% lower than
those of the human phosphoproteins and p-sites, respectively
(see Table 1 for details).
Estimation of Arabidopsis phosphoproteins and p-sites
Arabidopsis thaliana is a model flowering plant (a eu-dicot) with
∼28000 protein-encoding genes [15] and multiple tissues and
cell types. By mining the literature and applying our stringent
criteria, we have collected 28 HTP experimental datasets that
generated 14796 p-sites in 4930 phosphoproteins (see supple-
mentary file S4). The saturation level of theArabidopsis phospho-
proteins is depicted in Fig. 4A, while the estimates on their total
number, based on the different methods and data treatments,
are depicted in Fig. 4B. It is evident, especially from Fig. 4A (see fi-
nal data point), that the detection of phosphoproteins is far from
approaching saturation. Notably, the last experiment detected a
lot of new phosphoproteins, thus casting even more doubt as
to whether there are sufficient data to provide any reliable esti-
mates. Curve-Fitting estimates based on highly confident phos-
phoproteins that have been detected in three or more experi-
ments failed to provide a reasonable estimate. To make matters
worse, Curve-Fitting based on one-half of the experiments pro-
vided an unrealistically low number. Considering all the above
major concerns, an estimate of 4300 phosphoproteins provided
by Curve-Fitting seems unrealistic. On the contrary, the Capture-
Recapture method provided an estimate of 6500 phosphopro-
teins, but considering the significant contribution of the last
experiment, this estimate should be interpreted as a very con-
servative lower bound. Apparently, the publicly available data
have not yet reached saturation and thus are not sufficient to
provide a reliable estimate of the total number of phosphopro-
teins. As a consequence, any attempt to estimate the total num-
ber of p-sites in Arabidopsis is even more problematic.
Concerning the saturation level of p-sites, it is evident from
Fig. 4C (see final data point) that their detection is also far
from approaching saturation. Curve-fitting provided a dubious
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Figure 3: Estimation of the number of phosphoproteins (3A, 3B) and p-sites (3C, 3D) for mouse, with the Curve-Fitting (assuming 1 % noise) and Capture-Recapture
methods, also correcting for three levels of noise (1 %, 5%, 10%). See legend of Fig. 1 for explanations. Estimates on Fig. 3B and D are obtained for a Vega annotated
proteome of 16 000 protein-coding genes, where all estimates have been readjusted 25% upwards.
estimate of ∼24 000 p-sites. In addition, curve-fitting estimates
based on highly confident p-sites that have been detected in
three or more experiments provide an estimate of ∼35 000 p-
sites, but a visual inspection of the curve suggests that it still
follows a linear mode and therefore this estimate is, to say
the least, dubious. The Capture-Recapture method estimates
∼28 000 total p-sites. Therefore, a gross estimate of 24 000-35 000
p-sites is currently suggested by the data, but should be consid-
ered of very low confidence.
Discussion
Literaturemining and stringent filtering of 187 publicly available
HTP phosphoproteomic datasets was performed in this study so
as to compile the most comprehensive data compendia for hu-
man and threemodel eukaryotes: mouse,Arabidopsis, and yeast.
Two publicly available database compendia of low-throughput,
high-quality data (from PhosphoGrid2 and Phosphosite plus),
which serve as “gold-standards,” were also integrated. Based on
these compendia, estimates of the total number of phosphopro-
teins and p-sites within each proteome were calculated using
two different methods: (i) the Capture-Recapture approach that
is widely used in ecology and epidemiology to estimate popula-
tion size, and (ii) parameter optimization (Curve-Fitting) on the
saturation curve of cumulative redundant vs cumulative non-
redundant phosphoproteins/p-sites. Estimates for both meth-
ods were also re-adjusted for various levels of noise and pertur-
bations within the individual data. This analysis has generated
what we believe is the first set of approximate estimates of the
total number of phosphoproteins/p-sites in a range of species
that is based on established computational and statistical ap-
proaches and which also critically assesses their validity.
The field of phosphoproteomics still faces significant ex-
perimental and computational challenges [32]. Several studies
have reported that HTP phosphoproteomic experiments alone
may fail to capture many known p-sites, depending on vari-
ous parameters and protocols [5,18,24–28]. For example, consec-
utive proteolytic digestion by two or more enzymes increased
phosphoprotein and p-site detection by 40% to 70%, compared
to an experiment that used only one enzyme [25,26,28]. Along
the same line of evidence, a previous Proteomics analysis on
yeast showed that the use of additional proteases, apart from
the standard Trypsin resulted in a significant increase of pro-
teomics coverage from 21 % to 35% of total serines, threonines,
tyrosines [33]. Furthermore, the combined use of LysargiNase
with ETD not only increased the phosphoproteome coverage,
but also generated spectra that allowed for easier localization of
p-sites [34]. Thus, the proteomics community is exploring
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Figure 4: Estimation of the number of phosphoproteins (4A, 4B) and p-sites (4C, 4D) for Arabidopsis, with the Curve-Fitting (assuming 1 % noise) and Capture-Recapture
methods, also correcting for 3 levels of noise (1 %, 5%, 10%). See legend of Fig. 1 for explanations.
the consecutive use of many more than one proteolytic enzyme
[35]. P-sites are not evenly distributed across the proteome but
tend to cluster, especially at disordered regions [5, 36–38], thus
increasing the probability of missing many neighboring p-sites
due to problematic enzymatic digestion of that peptide region.
Also, the vast majority of the phosphoproteomic datasets are
generated by three enrichment methods (IMAC, TiO2, and p-Tyr
pull down) that are well known to exhibit relatively low over-
lap among them, due to inherent biases towards certain classes
of phosphopeptides [39,40]. Therefore, it is conceivable that a
significant fraction of phosphopeptides are still undetectable
from the current HTP protocols. Furthermore, several replicates
may be needed to capture a certain phosphoproteome in a cer-
tain condition, as revealed by the saturation analysis of four
technical replicates of the Tyrosine phosphoproteome in human
embryonic stem cells [9]. In addition, our analysis filtered and
retained phosphopeptides with very high (≥99%) p-site localiza-
tion probabilities. Therefore, some of the estimates only reflect
what the current technologies, under certain filtering criteria,
are capable of detecting if many experiments are performed.
Since current HTP phosphoproteomic technologies are
unable to capture all known p-sites, a specific Capture-
Recapture analysis was performed in yeast, human, and mouse
separately, where the total number of non-redundant HTP
phosphoproteins/p-sites were merged as one experiment and
the total number of non-redundant LTP phosphoproteins/
p-sites (obtained from PhosphoGrid2 and Phosphosite plus)
weremerged as a second experiment. In this case, the estimates
for phosphoproteins did not change significantly. For yeast, the
maximum estimates changed from ∼2800 to 2950 phosphopro-
teins (potential HTP detection at 94%); for human, the maxi-
mum estimates changed from 10200 to 12 800 phosphoproteins
(potential HTP detection at 80%); for mouse, the maximum es-
timates changed from 8300 to 11 200 (potential HTP detection at
74%). Indeed, many lines of evidence suggest that detection of
the phosphoproteome for yeast, and humans has approached
saturation, but this is less so for mouse. Nevertheless, concern-
ing the total number of p-sites, this particular approach revealed
that the current HTP technologies alone are capable of detect-
ing only ∼46% to 54% of the total. In yeast, the maximum esti-
mate for p-sites changed from 21000 to 40 000 p-sites (potential
HTP detection at 53%). The equivalent numbers for human are
from 125000 to 230 000 p-sites (potential HTP detection at 54%),
whereas formouse they are from 71000 to 156 000 (potential HTP
detection at 46%). This finding highlights the oft-neglected im-
portance of high-quality LTP studies and their expert annotation
in specialized databases that may serve as gold standards in the
Omics era.
The most reliable estimates provided in our analysis
are based on current datasets filtered and compiled from
HTP phosphoproteomics and also on LTP, but highly confi-
dent experiments. Thus, it is conceivable that future HTP
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phosphoproteomic technologies/protocols may significantly
change these estimates upwards, more probably for p-sites than
for phosphoproteins. The more saturated the detection of phos-
phoproteins and p-sites, the less variability will be observed
in the estimation of their total numbers with various methods
and dataset manipulations/perturbations. However, our analy-
sis provides a rigorous framework and a useful point of reference
for all future updates on these estimates.
Potential implications
Although HTP technologies will sooner or later mature to a level
that allows the discovery of the total number of p-sites within
a proteome, the real challenge that lies ahead is to determine
which ones are noisy and which ones have a functional effect
on phenotype [41–43]. Already, mutation studies of important p-
sites in combination with proteomics and flux analysis or untar-
geted metabolomics show the way forward [44–46]. Considering
the large number of p-sites estimated in this analysis, it is likely
that such a daunting challenge will need to be addressed by a
fusion of bioinformatics filtering analyses together with highly
automated HTP omics and experimental processes that assess
the phenotype of mutants [47,48].
Methods
The Capture-Recapture method
This method is widely used in epidemiology and ecology for
estimating unknown population sizes and has been imple-
mented in the R software package as the Rcapture mod-
ule [49]. It has also been implemented for the inference of
protein count in MudPIT experiments and for the inference
of human p-sites based on data from two databases [9,50].
In this approach, the population under investigation is sam-
pled several times and the observed pairwise overlap among
the various samples is used to estimate the total population
size. For our analysis, we assumed that the data resembled
a closed population, meaning a finite and stable maximum
number of phosphoproteins and p-sites. Another assumption
was that the data were subject to temporal and contextual
effects, meaning that the number of p-sites/phosphoproteins
detected in the various experiments is not necessarily the
same. A third assumption was that there is some heterogene-
ity among the different p-sites/phosphoproteins, implying that
each p-site/phosphoprotein has its own probability of being cap-
tured/detected. This assumption is in accordance with a model
of some proteins being expressed/phosphorylated most of the
time, whereas other proteins are expressed/phosphorylated
more transiently. Based on the Akaike information criterion test
[51], embedded within the RCapture software, the Chao Mth
model (M standing for model; t standing for temporal; h stand-
ing for heterogeneous) was selected for the subsequent analy-
ses. The method is implemented in R and may input up to 15
to 20 different samples, depending on their size, as a matrix in-
put file. Once the user loads the matrix input file in R, where
each row represents a protein or p-site and each column rep-
resents an experimental dataset (with 0 for absence and 1 for
presence), the Capture-Recapture method is run by executing
the “closedp(matrix)” function. Due to this limitation, original
estimates for each species were based on the 15 largest datasets.
To allow for variation, the Capture-Recapture analyses on hu-
man and mouse were repeated with a jackknife strategy, where
only datasets with 500 or more p-sites were retained. Next,
within this retained subset, jackknife randomly selected 15 of
those experiments and then calculated the population size,
standard deviation, and coefficient of variation. This jackknife
approach was repeated 100 times for each of the two species.
Estimation based on curve-fitting of data saturation
The secondmethod employedwas based on graphing, in a given
scatter plot, the cumulative number of non-redundant (unique)
phosphoproteins/p-sites (y-axis of a given scatter plot) identi-
fied as relevant experiments accumulated over time against the
cumulative number of redundant p-sites/proteins (x-axis of a
given scatter plot). In essence, it constitutes a visualization of
the saturation level of the experiments. For example, if one as-
sumes that one experiment identifies 1000 p-sites, then, up to
this point, the total number of unique p-sites is 1000. A sec-
ond experiment identifies 900 p-sites, but 100 of those were
identified previously. Therefore, at the time of the second ex-
periment, 1900 redundant p-sites have accumulated (x-axis of
a given scatter plot), whereas the cumulative number of unique
p-sites now rises to 1800 (y-axis of a given scatter plot). In such a
process, the cumulative number of non-redundant units (phos-
phoproteins or p-sites) rises steeply at the beginning and very
slowly later asmore andmore experiments accumulate. The cu-
mulative number of units will converge to a plateau value that
approximates the total number of units in that proteome. This
process is best modeled by an exponential recovery curve. In-
deed, simulations of such a process verified the exponential na-
ture of recovery, which is modeled by equation 1:
y = a ∗ (1 − e(−x/b))
In this equation, x is the cumulative number of redundant
units (p-sites/phosphoproteins), y is the cumulative number of
non-redundant units that have been identified up to that point,
a is a constant that reveals the maximum value of y (that is ac-
tually the estimated total number of non-redundant units), and
b is a constant that defines the steepness of the curve and is
the total number of redundant units needed to be detected in
order to identify 63.2% of total non-redundant units. Estima-
tion of the above parameters was performed with Curve-Fitting
in Microsoft Excel, by optimizing the a and b parameters with
the GRG non-linear solving method, to minimize the sum of
squared errors between the observed and theoretical values. The
curve-fitting process is explained in detail in supplementary file
S6, which is a screencasting mp4 video.
Controlling for various confounding factors
Highly similar experimental datasets may artificially inflate the
observed saturation of the sampled population. Therefore, it
is necessary to assess the level of pairwise overlap among the
various experiments to exclude any highly similar datasets. To
achieve this, the Jaccard distance and similarity (1 – Jaccard dis-
tance) between all pairs of experiments (within a species) was
estimated with the pdist function in Matlab. This distance is
used for binary variables (in this case, 1 and 0 for detection or
non-detection of phosphorylation of a protein/site in a certain
experiment). This distance is the quotient between the intersec-
tion and the union between two experiments. The results of the
Jaccard distance between the various experiments is summa-
rized in supplementary excel file S7. For proteins, the average
andmaximum Jaccard similarities ranged between 0.07 and 0.24
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and between 0.51 and 0.63, respectively. For p-sites, the average
and maximum Jaccard similarity ranged between 0.04 and 0.09
and between 0.27 and 0.5, respectively. Thus, all experiments
were included in subsequent analyses.
Any HTP experiment is susceptible to noise and phosphopro-
teomics is no exception. Furthermore, current analyses of mass
spectra are usually performed automatically, by algorithmswith
varying probabilities of error. The phosphoproteomic experi-
ments that were used in this study were further filtered with
a cut-off of 99% correct phosphopeptide identification and 99%
correct p-site localization. However, these are values provided
by the various phosphoproteomic software packages.
To model the effect of noise on our estimates, three basic
assumptions were made: (i) noise has a stochastic nature, (ii)
the pool of noise (potential false-positive p-sites and phospho-
proteins) is large, and (iii) the level of noise within a given ex-
periment is relatively low. Assuming that the above three as-
sumptions are reasonably valid, it is expected that the overlap
of false-positive p-sites/phosphoproteins among the various ex-
periments is very small, if not negligible.
For the Capture-Recapture algorithm, the presence of such
noise is expected to cause the algorithm to overestimate the to-
tal number of p-sites, due to the presence of non-overlapping
false-positive identifications in the various datasets. To re-
adjust the estimates, 1 %, 5%, and 10% more noise was added
to all the current datasets and the consequent increase in the
estimates made by the algorithm determined. Based on the
results from this artificial increase, an appropriate downward
adjustment of the original estimates was made for each partic-
ular level of noise.
The effect of noise can be modeled in the curve-fitting ap-
proach as well. Here, the number of false-positives in the com-
pendium will increase for some time in a linear fashion (due
to negligible overlap). Thus, while the number of experiments
continues to increase, the number of new true-positives will
plateau, whereas noise will cause false-positives to continue to
accumulate in a linear fashion, as shown in equation 2:




+ c ∗ x,
where: c is now the average noise level within the experiments.
It is conceivable that the curve-fitting estimates may be af-
fected by the order in which the experiments were performed
(or, at least, published). To control for such a possibility, the or-
der of the experiments was changed in two ways, such that the
largest experiment was placed either first or last in the temporal
order and the parameters of the curve re-calculated. In addition,
the curve-fitting parameters were recalculated, but only for the
earlier half of the experiments on each species. In these ways,
it is possible to determine the extent to which the estimates are
affected by the temporal ordering of the experiments and thus
assess their robustness.
Evaluation of the two methods on the yeast proteome
To assess how reliable are the two methods of Capture-
Recapture and Curve-Fitting of the saturation curve, estimates
were calculated for a published proteomics experiment with a
known outcome. Five proteomics experiments were performed
for yeast [33], during normal growth conditions and by using five
different proteases for peptide cleavage, ArgC, GluC, LysC, AspN,
and Trypsin. Each of the five experiments identified between
2674 and 3264 yeast proteins. By combining all five datasets,
these protocols were capable of identifying ∼3900 yeast pro-
tein, out of an estimated (based on GFP and TAP-tag) 4500, ex-
pressed in normal growth conditions [52]. In our analysis, each of
the five experiments was randomly downsampled to 50%. After
downsampling, the RCapture method estimated a total of 3805
proteins, whereas the Curve-fitting of the saturation curve esti-
mated a total of 3732 proteins, which were very close to the total
identification of 3908 proteins, based on these HTP technologies.
Results are shown in Supplementary file S8.
Availability of supporting data
All supplementary data can be downloaded from our labora-
tory web site (http://bioinf.bio.uth.gr/total-phosphoproteome-
estimate.html).
The p-sites for each of the four species are organized in sep-
arate files (S1–S4) in csv format, where each row corresponds to
the protein and the phosphorylated aminoacid (numbered) and
each column corresponds to the published dataset (Pubmed ID
in the first row) that it was detected as phosphorylated. All arti-
cles that were used to extract data are found in Supplementary
excel file S5. The Supplementary Mp4 video (S6) demonstrates
the implementation of Curve-fitting in Microsoft Excel. Of note,
the Solver add-in needs to be installed first. The Supplemen-
tary excel file S7 contains the results of the Jaccard distance be-
tween the various datasets of each species. The Supplementary
excel file S8 contains the evaluation of the Capture-Recapture
and Curve-fitting on the five yeast proteomics experiments (five
proteases) (each randomly downsampled at 50%) of Swaney
et al. [33]. The supporting data associated with this manuscript
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